SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹61 Cr | ₹52 Cr | ₹23 Cr | ₹19 Cr |
What is the latest Net Current Assets ratio of SHREE GANESH REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹52 Cr |
| Mar2020 | ₹23 Cr |
| Mar2019 | ₹19 Cr |
How is Net Current Assets of SHREE GANESH REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹61 Cr | 19.16 | |
| Mar2024 | ₹52 Cr | 119.82 | |
| Mar2020 | ₹23 Cr | 23.20 | |
| Mar2019 | ₹19 Cr | - | |
Compare Net Current Assets of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹655.6 Cr | 1.1% | 22.6% | -31.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 1.1% |
22.6% |
-31.2% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses